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Multi-electrode arraysIn this study, we used high-speed video microscopy with motion vector analysis to investigate the contractile
characteristics of hiPS-CMmonolayer, in addition to further characterizing themotionwith extracellular ﬁeld po-
tential (FP), traction force and the Ca2+ transient. Results of our traction forcemicroscopy demonstrated that the
force development of hiPS-CMs correlated well with the cellular deformation detected by the video microscopy
with motion vector analysis. In the presence of verapamil and isoproterenol, contractile motion of hiPS-CMs
showed alteration in accordance with the changes in ﬂuorescence peak of the Ca2+ transient, i.e., upstroke,
decay, amplitude and full-width at half-maximum. Simultaneously recorded hiPS-CM motion and FP showed
that there was a linear correlation between changes in themotion and ﬁeld potential duration in response to ve-
rapamil (30–150 nM), isoproterenol (0.1–10 μM) and E-4031 (10–50 nM). In addition, tetrodotoxin (3–30 μM)-
induced delay of sodium current was corresponded with the delay of the contraction onset of hiPS-CMs. These
results indicate that the electrophysiological and functional behaviors of hiPS-CMs are quantitatively reﬂected
in the contractile motion detected by this image-based technique. In the presence of 100 nM E-4031, the occur-
rence of early after-depolarization-like negative deﬂection in FP was also detected in the hiPS-CM motion as a
characteristic two-step relaxation pattern. These ﬁndings offer insights into the interpretation of the motion
kinetics of the hiPS-CMs, and are relevant for understanding electrical and mechanical relationship in hiPS-CMs.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Human-induced pluripotent stem cell-derived cardiomyocytes
(hiPS-CMs) and human embryonic stem cell-derived cardiomyocyte
(hES-CMs) hold promise for the applications in cardiac cell biology [1],
drug development [2–6] and cardiac therapeutics [7–11]. To date,
hiPS-/hES-CMs have been characterized largely based on studies that
examined the aspects of the electrophysiology or the Ca2+ signaling/
handling [3,12–20]. This is in contrast to the contractile characteristics of, cardiomyocyte; CRD, contrac-
tialduration;FPslow, slowsignal
S-CM, human-inducedpluripo-
ryonicstemcell-derivedcardio-
lectrode array;MRS,maximum
on force; TFM, traction forcemi-
81 3 5803 4790.
81 3 5803 0364.
. Hayakawa),
. This is an open access article underthe hiPS-/hES-CMs, as there have been few studies performed at the pres-
ent time [21–29]. Limited numbers of studies, however, demonstrated
that hES-CMs showed chronotropy but no signiﬁcant inotropy in re-
sponse to β-adrenoceptor agonist, isoproterenol, by using a force trans-
ducer for three-dimensionally (3D) engineered hES-CM tissue [29] or
for co-culture systemof hES-CMswith non-contractile slices of neonatal
murine ventricles [28]. These results suggest the importance of
performing a phenotype evaluation for hiPS-/hES-CMs based on the
contractile properties as well as electrophysiological characteristics to
assess their adaptability to the applications. In addition, a report that
used atomic force microscopy to investigate two-dimensionally (2D)
cultured hiPS-CMs from patients with dilated cardiomyopathy (DCM)
demonstrated that the DCM hiPS-CM exhibited a phenotype that was
based on the perturbed contractility rather than on the electrophysio-
logical abnormality [27,30]. This demonstrated the need for developing
methodologies that characterize the electrical and mechanical relation-
ship of hiPS-/hES-CMs.
In our current study, we combined phase-contrast videomicroscopy
and multi-electrode array (MEA) measurement in order to investigate
the relationship between the contractile motion and the extracellularthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cardioactive agents. The label-free video microscopy is a method of
choice for evaluating the contractile characteristics of CMs, and many
researchers have reported the applicability in various culture
conditions [31–40]. For example, for isolated rod-shaped adult CMs,
the shortening length and velocity of contraction of whole cell body or
sarcomere were evaluated quantitatively using video microscopy with
edge-detection technique [34,41–43]. Edge-detection method was
also applied to the contractility estimation of embryonic bodies with
hES-CMs [44,45]. Kamgoue et al. applied image correlation analysis for
single adult and neonatal rat CMs, and detected intracellular strains
quantitatively from the calculated 2D displacement ﬁeld [36]. Modiﬁed
image correlation analysis was developed by Ahola et al. for single hiPS-
CMs, which exhibits heterogeneous in shape, to evaluate the detailed
intracellular deformation [46]. Beating frequency of mouse ES-CM
monolayer has been evaluated based on the image analysis of transmit-
ted light intensity change [35] and the fast Fourier transform technique
[39].Meanwhile,we have previously reported the applicability of image
correlation analysis, or motion vector analysis, for analyzing video im-
ages of neonatal rat CM monolayers [47]. By calculating the velocity
ﬁeld over thewhole image, thismethod hasmade it possible to evaluate
the average contractile speed, global deformation and contraction prop-
agation in the CMmonolayer with high spatiotemporal resolution [47].
Due to the convenience and non-invasiveness, such label-free video
microscopies would be advantageous for the readout method of hiPS-/
hES-CM behaviors, especially for the applications in therapeutics and
drug safety assessment. In addition, since microscope observation itself
does not interfere with the electrophysiological measurements, video
microscopies are amenable to the simultaneous measurement with
electrical measurements, e.g., patch clamping and MEA, to gain greater
insight into the electro-mechanical correlations of CMs.
In this study, we further performed traction force microscopy and
Ca2+ imaging in the hiPS-CMs in order to discuss the association of con-
tractile motion to force development and Ca2+ transient, respectively.
Our results showed that electrophysiological and functional behaviors
of the 2D-cultured hiPS-CMs are quantitatively reﬂected by contractile
motions detected with high-speed video microscopy. These ﬁndings
offer insights into the interpretation of motion kinetics of hiPS-CMs,
and are relevant for understanding electrical and mechanical relation-
ship in hiPS-CMs. These results also demonstrate that it is possible for
us to broaden the scope of application for hiPS-CMs for use in even
simple culture conditions.
2. Materials and methods
2.1. hiPS-CMs and cell preparation
The hiPS-CMs used in this study were purchased from Cellular
Dynamics International, Inc. (CDI) (iCell Cardiomyocytes, CDI,
Madison, WI, USA). The iCell CMs are highly puriﬁed human CMs
(N98% pure cardiomyocytes) that are derived from iPS cells using
previously described differentiation and puriﬁcation protocols [48].
The iCell CMs were seeded and maintained according to the protocol
recommended by the supplier using iCell Cardiomyocytes Plating
Medium (CDI) and iCell Cardiomyocytes Maintenance Medium
(CDI) at 37 °C, 7% CO2. The details on the cell preparation for MEA
recordings, Ca2+ transient measurements and TFM are provided in
the Supplementary materials.
2.2. Video microscopy
A high-speed digital CMOS camera (KP-FM400WCL, Hitachi Kokusai
Denki Engineering, Tokyo, Japan) was mounted on an inverted micro-
scope (Eclipse Ti, Nikon, Tokyo, Japan). Movie images of beating hiPS-
CMs were recorded as sequential phase-contrast images with a 10×
objective at a frame rate of 150 fps, a resolution of 2048 × 2048 pixels,and a depth of 8 bits. Further details on the video imaging are provided
in the Supplementary materials.
2.3. Motion vector analysis
Motion vectors of beating hiPS-CMs were obtained using a block
matching algorithm, as has been described elsewhere [47,49]. Further
details on themotion vector analysis are provided in the Supplementary
materials.
2.4. Traction force microscopy
2.4.1. Fabrication of polyacrylamide hydrogel substrates and hiPS-CM
seeding
Polyacrylamide hydrogel substrates containing ﬂuorescence beads
(#G0100, 1 μm diameter, Ex/Em = 468/508 nm, Duke Scientiﬁc Co.,
CA, USA) were fabricated in accordance with previously reported
methods [26,50,51]. Further details on the methods are provided in
the Supplementary materials.
2.4.2. Traction force microscopy
Video of the hiPS-CMs cultured on polyacrylamide gel was captured
using phase-contrast and ﬂuorescence microscopy to detect contractile
motion and substrate deformation, respectively. Estimation of the
force development of hiPS-CMs was performed by a particle image
velocimetry (PIV) [52] and Fourier transform traction cytometry
(FTTC) [51–53] programs implemented as an ImageJ plugin. Details
are provided in the Supplementary materials.
2.5. Simultaneous recordings of FP and motion
MED probes (MED-P515A, Alpha MED Sciences, Osaka, Japan)
equipped with platinum black-coated 64 planar microelectrodes that
were arranged in an 8 × 8 grid embedded in the center of a transparent
glass plate were used for extracellular recordings of the FP from the CM
monolayer [54]. The details on the cell preparation for MEA recordings
are provided in the Supplementary materials. Image acquisitions and
multi-electrode array (MEA) recordingswere synchronized using exter-
nal triggering options of the MEA system. Data were recorded simulta-
neously for the 64 electrodes (sampling frequency; 20 kHz,
bandwidth; 1–1000 Hz) and were analyzed by Mobius Software
(Alpha MED Sciences) in order to detect the ﬁeld potential duration
(FPD). In this study, we averaged at least 10 consecutive FP waveforms
to evaluate the ﬁeld potential parameters. The details on the simulta-
neousmeasurements are also provided in the Supplementarymaterials.
2.6. Calcium imaging
For imaging of the Ca2+ transient in the hiPS-CMs, iCell
Cardiomyocytes (CDI) were plated in a 96-well plate pre-coated
with rat collagen type I (BD, Franklin lakes, NJ) at a density of
3 × 104 cells/well (cultured with 100 μl medium). hiPS-CMs were
loaded with Fluo-5F/AM (Invitrogen, Carlsbad, CA, USA) dissolved in
dimethylsulfoxide (DMSO, WAKO Pure Chemical, Osaka, Japan) and
added to the culture medium at a concentration of 5 μM in preparation
for the Ca2+ imaging. After 30 min incubation, the culture dishes
were placed on a microscope stage (IX-71, Olympus, Tokyo, Japan).
Ca2+ ﬂuorescence images were captured with a digital CCD camera
(CoolSNAP HQ2, Photometrics, Tucson, AZ, USA) at a resolution of
696 × 520 pixels and 33 fps using a 20× objective and recorded using
MetaMorph software (Molecular Devices, Sunnyvale, CA, USA). The
data were then quantiﬁed as the background subtracted ﬂuorescence
intensity changes (ΔF) normalized to the baseline ﬂuorescence (F0)
using the ImageJ software and the KaleidaGraph software ver. 4.1.1
(Synergy Software, Reading, PA, USA). Amplitudes, full-width at half-
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also analyzed with the KaleidaGraph software.
2.7. Cardioactive substances
Isoproterenol was purchased from Sigma (St. Louis, MO, USA),
E-4031 and tetrodotoxin fromWAKO Pure Chemical Industries, and ve-
rapamil from Nacalai Tesque (Kyoto, Japan). Stock solutions for isopro-
terenol and E-4031 were prepared in distilled water, while verapamil
was prepared in DMSO. All stock solutions were further diluted in
culture medium, with the ﬁnal concentration of DMSO less than 0.05%.
Four to six increasing concentrations of the test substanceswere applied
consecutively for 10 min each.
2.8. Statistical analysis
Data are compared to control in the paired t-test for the grouped
data. Data are presented as means ± SEM. The value was expressed as
a percentage of the control value, while the comparison was made
using raw values of each parameter. We considered p values less than
0.05 to be statistically signiﬁcant.
3. Results
3.1. Motion vector detection as a reliable representation of contractile
characteristics of hiPS-CMs
3.1.1. Motion vector detection from the movie image of single hiPS-CMs
We ﬁrst evaluated the contractile motion of single hiPS-CMs.
Sparsely plated hiPS-CMs exhibited heterogeneous shapes and a variety
of sizes (Fig. 1A). Fig. 1B shows an example of single hiPS-CM motion
detected by the motion vector analysis. As indicated by the motion
vectors that overlay the image of hiPS-CM, cellular deformation gener-
ally occurred toward the center direction of the cell body during
contraction process (Fig. 1B (1)). After a transient pause of cellular
motion (Fig. 1B (2)), the cell body returned to the position of resting
state, exhibiting a slower motion speed than that observed during con-
traction (Fig. 1A (3)). By averaging themagnitude ofmotion vectors and
plotting them against time, we were able to obtain information on the
contraction and relaxation motion (Fig. 1C), along with the frequency
(Fig. 1D). Although the contraction and relaxation occurs in the opposite
direction, the average of vector magnitude is a positive value, thereby
resulting in a two-positive peak proﬁle that reﬂects the contraction–
relaxation process. As seen in Fig. 1E, we are able to extract various
parameters regarding contractile motion from this two-peak motion
proﬁle. Our current study primarily examined four parameters of this
hiPS-CM motion. These included the maximum values of the average
magnitude of motion vectors during the contraction (a) and relaxation
(b) processes (termed MCS; maximum contraction speed and MRS;
maximum relaxation speed, respectively), the total area under two
peaks (c) (representing the average deformation distance (ADD) during
the contraction–relaxation process), and the duration of contraction
and relaxation motion (d) (with the duration between the onset of
the contraction peak and the offset of the relaxation peak deﬁned as
the contraction–relaxation duration (CRD)). Fig. 1F–I shows contractile
parameters of single hiPS-CMs (n = 40) cultured in physiological
condition (37 °C and 5% CO2). Single hiPS-CMs exhibited beating rate
ranging from ~20 to ~110 beats per minute (bpm) with the average
of 62 bpm. Analysis of motion vectors showed that the average values
of MCS, MRS, CRD and ADD were 8.2 μm/s, 4.1 μm/s, 455 ms and
1.07 μm, respectively, and the average cell area was found to be
4244.3 μm2. We examined to plot the cell area against MCS and MRS,
and found that contractile speeds were not signiﬁcantly dependent on
the cell area (Fig. 1K). CRD of single hiPS-CMs showed a linear correla-
tion with the beating rate with the correlation coefﬁcient of 0.768
(Fig. 1L).3.1.2. Contractile motion and traction force of the hiPS-CMs
Subsequently, we used traction force microscopy (TFM) to assess
whether the cellular deformation, detected by phase-contrast mi-
croscopy and motion vector analysis, was correlated with the force
development of hiPS-CMs on the elastic substrate (polyacrylamide
gel). Fig. 2 shows a typical image of a hiPS-CM on the gel substrate
(12 kPa) examined by phase-contrast (a) and ﬂuorescencemicrosco-
py (b). Typical images of displacement and traction force ﬁelds that
were calculated from the two ﬂuorescence images (taken before
and after contraction) are also shown in Fig. 2A(c) and (d), respec-
tively. We then compared the ADD and the traction force of hiPS-
CMs on the elastic substrate (12 kPa and 50 kPa). As shown in
Fig. 2B, a linear correlation was observed for the traction force and
the ADD of the single hiPS-CMs cultured on gel substrates, with a
correlation coefﬁcient of 0.737 (n = 13) and 0.595 (n = 12) for the
hiPS-CMs on the 12 kPa and 50 kPa substrates, respectively. These re-
sults suggested that the cellular deformation detected with motion
vector analysis could be used as a surrogate of the traction force de-
veloped by the hiPS-CM contraction.
3.1.3. Ca2+ transient and contractile motion of hiPS-CMs
To verify the relationship between the contractile motion and the
cytoplasmic Ca2+ concentration, we further examined the parameters
of the Ca2+ transient of the hiPS-CMs. Fig. 3A and B show the typical ex-
amples of Ca2+ transient and motion waveform of hiPS-CMs, respec-
tively, in the absence and the presence of 100 nM isoproterenol.
Isoproterenol altered the amplitude, maximum upstroke, maximum
decay and full-width at half-maximum (FWHM) of the Ca2+ transient
with 113, 114, 157 and 84% of the control, respectively (see bar charts
in Fig. 3A). Isoproterenol also altered the contractile parameters,
i.e., ADD, MCS, MRS and CRD were changed to 113, 124, 146 and 80%
of the control, respectively (Fig. 3B). In contrast, verapamil (100 nM)
decreased all of the parameters of Ca2+ transient and contractilemotion
except the decay of Ca2+ transient (Fig. 3C and D). As shown in the bar
charts in Fig. 3C and D, verapamil altered the Ca2+ transient amplitude,
upstroke, decay and FWHMwith 63, 78, 97 and 66%, respectively, while
ADD,MCS,MRS andCRDwith 52, 62, 63 and 66%, respectively. These re-
sults suggested that the contractile parameters of hiPS-CMs correspond
to the intracellular Ca2+ status.
3.2. Correlation between the FP and the contractile motion of hiPS-CMs
We next performed a simultaneous recording of the contractile
motion and FP using a hiPS-CM monolayer cultured in a MEA dish. To
accurately evaluate the relationship between the motion and the FP of
hiPS-CMs, the motion vectors were calculated from the hiPS-CMs that
were located close to the vicinity of the electrodeused for FP data collec-
tion. The yellow-squared area (150 × 150 μm) in Fig. 4A represents an
example of the region that was used for evaluating contractile motion.
Fig. 4B is an enlarged image, in which the calculated motion vectors
(ﬁnewhite bars) are overlaid on the image of the yellow-squared region
shown in Fig. 4A. The MCS was ~10 to ~20 μm/s in normal culture con-
ditions (e.g., 37 °C, 5% CO2 and ~100% humidity) in the absence of any
drugs. The simultaneously measured FP exhibited a typical waveform
that had a sharp initial negative deﬂection, which is supposedly corre-
lated with the inward Na+ current. This is followed by a broad negative
deﬂection (FPslow) and a terminal positive deﬂection, which is suppos-
edly correlatedwith the inward Ca2+ and outward K+ currents, respec-
tively [55–58]. As seen in the waveforms presented in Fig. 4C, D and E,
several features of the relationship between the motion and the FP of
hiPS-CMs were identiﬁable. These included 1) the CRD was longer
than the FPD. The end of the FPD was previously deﬁned as either the
peak of the positive deﬂection [6,54,55,59] or the point where the pos-
itive deﬂection returns to the baseline [60]. The former end-point ap-
pears to be correlated with the upstroke of relaxation motion, while
the latter end-point appears to be correlatedwith the peak of relaxation
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difﬁcult to establish. Other observed features included 2) the onset of
the contraction motion follows the occurrence of the Na+ current
peak of the FP (see Fig. 4E), and 3) the position of FPslow occurs with
the contraction. The relationships between the motion proﬁles and
the FP for the hiPS-CM described in 1) and 2)were also found in neona-
tal rat CMs (Supplementary Fig. 2). However, the point 3) was not ob-
served in rats. In the neonatal rat CMs, the entire FPslow was localized
within the contraction motion and the broad positive deﬂection of the
FP positions near the end of contraction motion (Supplementary
Fig. 2B).(A)
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Fig. 1.Motion vectors detected during the contraction and relaxation process of a single hiPS-CM
polystyrene dish, which was captured using a 10× objective. (B) Contractile motion of the hiPS
upper panels, motion vectors show the velocity ﬁeld at contraction (1), at the end of contraction
ﬁeld in a heat-map style that corresponds to theupper panels. (C) Example of amotionwaveform
in (B). Points (1)–(3) correspond to the same time points in the picture in part (B). (D) The train
motionwaveform of CMcontraction–relaxation obtainedwithmotion vector analysis. a–c in (E
speed (MCS), b: maximum relaxation speed (MRS), c: average deformation distance (ADD) a
parameters and cell-area of single hiPS-CMs (n = 40), evaluated with motion vector analysi
maximum contraction and relaxation speed (MCS and MRS). MCS and MRS were assessed f
lines represent linear regression for MCS (black dots) and MRS (gray dots), respectively. (L) Co3.3. Correlation between the FP and the contractile motion of hiPS-CMs in
the presence of drugs
To determine the correspondence between the contractilemotion of
the hiPS-CMs and the electrophysiological behavior obtained by the
MEA technique, we examined various drugs that are known to inhibit
Na+, K+ and Ca2+ channels.
3.3.1. The effects of a Na+ channel blocker, tetrodotoxin (TTX)
It has been reported that Na+ channel blockers decreased the ampli-
tude and slope of the initial negative spike of FP waveform of CM3)
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182 T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191cultures [55,58,61]. To conﬁrm the correspondence of these effects on
the contractile behaviors of hiPS-CMs, we simultaneously recorded FP
andmotion of hiPS-CMs in the presence of 0–30 μMof TTX (Fig. 5A). En-
largement of the onset region of Fig. 5A is shown in Fig. 5B. The FP dura-
tion from the onset of the positive spike to thepeakof thenegative spike
was signiﬁcantly prolonged to 161% and 212% of the control at 9 and
30 μM of TTX, respectively, while the FPD measured as the duration
between the initial negative peak and the peak of positive deﬂection in-
creased to 106% and 110% of the control at the same concentrations.
Along with the delay of the spikes, the Na+ peak of FP exhibited broad-
ening and a decrease in the peak slope. The contraction motion also
exhibited a delay in the onset and peak position. As shown in Fig. 5C,
the durations from the onset of the positive FP spike to the peak of the
negative FP spike were linearly correlated with the durations from the
onset of the positive FP spike to the onset of the contraction motion
peak (R = 0.856). Although there was a progressive decrease in
the beating rate in accordance with increasing TTX concentrations
(Fig. 5G), no major increases in the FPD or CRD were observed
(Fig. 5D and G). While the MRS was nearly unaffected, there was asigniﬁcant decrease in the MCS (Fig. 5E). Despite this major decrease
in the MCS, there was no signiﬁcant alteration in the ADD (Fig. 5F).
3.3.2. The effects of a K+ channel blocker, E-4031
A K+ channel (IKr) blocker, E-4031, prolonged FPD of hiPS-CMs de-
pending on the concentration (Fig. 6A), which is in line with previous
reports [54,62]. The motion proﬁle exhibited a prolongation of CRD,
with a signiﬁcant decrease in MRS (Fig. 6A). FPD and CRD showed a
linear relationship in the presence of 0–50 nM E-4031 (Fig. 6B) with a
correlation coefﬁcient of R = 0.915. The slope of the linear regression
was 1.362 (FPD/CRD). In the presence of 100 nM E-4031, the hiPS-
CMs exhibited an EAD-like FP proﬁle (Fig. 6A and C), i.e., there was an
occurrence of negative deﬂection prior to the positive deﬂection. Since
it was difﬁcult to deﬁne the peak point of positive deﬂection, associated
with K+ current, or FPD in FP waveforms with EAD, we eliminated the
data with EAD-like waveform from the evaluation of the CRD–FPD
correlation (Fig. 6B). As shown in Fig. 6A and C, the motion proﬁle also
exhibited an irregular relaxation pattern that corresponded to the
EAD-like FP waveform. This indicates that the speed of the relaxation
(A) (B)
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Fig. 2. (A) Parts (a) and (b) show the phase-contrast and ﬂuorescent images of the hiPS-CMand the substratewith ﬂuorescence beads (1 μmdiameter), respectively. Part (c) is an example
of a displacement ﬁeld image ofﬂuorescence beads calculated by the particle image velocimetry (PIV) algorithm. Part (d) shows an example of a traction forceﬁeld image calculated using
the PIV result from part (c) by the Fourier transform traction cytometry (FTTC) method. (B) Correlation between ADD and the normalized traction force (at 12 kPa (●) and 50 kPa (▼))
estimated with the FTTC algorithm. Bar in (a) represent 50 μm. The color scales for (c) and (d) are as indicated beside each of the ﬁgures.
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deﬂection in the FP (see also Supplementary Movies 1 and 2). In the
presence of 100 nM E-4031, there was a major decrease in the contrac-
tile parameters, MCS, MRS, ADD and the beating rate (Fig. 6E–G).
3.3.3. The effects of a Ca2+ channel blocker, verapamil
Fig. 7A shows the alterations in the motion and FP proﬁles of the
hiPS-CMs in accordance with the verapamil concentration (0, 90,
150 nM). Increasing the verapamil concentration caused a progressive
decrease in both the FPD and CRD that waswell correlatedwith the cor-
relation coefﬁcient (R= 0.970) (Fig. 7B). The slope of the linear regres-
sion was found to be 0.633 (FPD/CRD). Since verapamil has an L-type
Ca2+-channel inhibiting effect, increasing verapamil concentration led
to a decrease in FPslow (Fig. 7A). Addition of verapamil also caused
MCS to become smaller. There was a good correlation between the am-
plitudes of FPslow andMCS, when these parameters were evaluated as a
percent of the control, with a correlation coefﬁcient of 0.921 (Fig. 7C).
Increasing verapamil concentration also caused the MRS as well as
ADD to decrease (Fig. 7C and D), and the beating rate to increase
(Fig. 7E).
3.3.4. The effects of the positive inotropic reagent, isoproterenol
Fig. 8A shows the simultaneouslymeasuredmotion and FP proﬁle at
isoproterenol concentrations of 0, 1, and 10 μM.With increasing isopro-
terenol concentrations, the CRD and FPD progressively shortened
(Fig. 8A), with a good correlation observed (R = 0.943) (Fig. 8B). The
slope of the linear regression was found to be 0.737 (FPD/CRD). For
the motion proﬁle, there were increases in the MCS, MRS, ADD as well
as the beating rate, all depending on isoproterenol concentrations
(Fig. 8C and D). These results suggest that the inotropic, lusitropic and
chronotropic effects of isoproterenol can be detected with the motion
of hiPS-CMmonolayer.
3.4. Variability in contractile data
To test the possibility that contractile parameters of hiPS-CMs
detected with the motion vector analysis is critically inﬂuenced by the
heterogeneity inmonolayer preparation,we evaluated the regional var-
iability inMCS andMRS.MCS andMRSwere obtained frommotion data,
and are summarized in Supplementary Fig. 3A andB. The average values
of MCS and MRS under control conditions varied from 8 to 15 μm/s and
from 4 to 10 μm/s, respectively, and were dependent on the regions ofmonolayer. These values were altered by the addition of a Ca2+ channel
blocker, verapamil, which had a negative inotropic effect and similar
variability to that of the control. By expressing these values to a percent
of the control, we found that each value converged to a similar percent-
age value (Supplementary Fig. 3A and B). This indicates that the relative
values of contractile parameters are signiﬁcantly less dependent on the
region in the preparation.
4. Discussion
The present study aimed to evaluate contractile characteristics and
the correlation between contractile motion and electrical properties of
hiPS-CMmonolayer by using videomicroscopy, Ca2+ transient imaging,
traction forcemicroscopy and FPmeasurement. High resolutionmotion
vector analysis could detect contractile characteristics of hiPS-CMs,
i.e., MCS, MRS, ADD and CRD, quantitatively, and demonstrated the cor-
respondence between contractile motion and FP. Motion data further
provided complementary information against FP, by detecting the ino-
tropic and lusitropic effects of an experimental drug, isoproterenol.
The accessibility to information about relaxation process, or lusitropism,
is considered to be one of the advantages of this imaging approach. Re-
cently, there has been increasing attention to the diastolic dysfunction
characterized by decreased relaxation velocity and prolonged relaxation
and its applicability to common cardiac pathologies, such as ischemic
heart diseases and hypertensive heart diseases, and to rare genetic
heart diseases, such as DCM [63,64]. The imaging approach could
potentially be used to target and analyze hiPS-CMs derived from such
diseases.
4.1. Contractile characteristics of hiPS-CMs detected with video microscopy
It has been previously reported that alterations in hiPS-CM area de-
pend on substrate stiffness [26] or cell density [65]. We examined the
cell area and the contractile parameters (MCS and MRS) of hiPS-CMs
(n= 40) and observed no signiﬁcant dependence of MCS and MRS on
cell area. Since in our current study, we sparsely plated hiPS-CMs in
order to extract single cell information, average cell area became rela-
tively larger (4244 ± 279 μm2, n = 40) than that recently reported
(1654 μm2, n = 22) for hiPS-CMs (iCell CMs) that were plated in a
monolayer form with a density of 22,500 cells in the well of a 96-well
multiplate [65]. As seen in Fig. 1, the hiPS-CMs attached to the substrate
exhibited a heterogeneous shape and their contractile motion often
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Fig. 3. (A) and (B) show the example proﬁles of the Ca2+ transient and motion waveform of hiPS-CMs, respectively, in the presence of 100 nM isoproterenol. (C) and (D) also show the
example proﬁles of the Ca2+ transient and motion waveform of hiPS-CMs, respectively, in the presence of 100 nM verapamil. The bar charts in (A) and (C) represent the drug-induced
change in amplitude, maximum upstroke, maximum decay and FWHM of the Ca2+-transient. In (B) and (D), change rate of the contractile parameters, ADD, MCS, MRS and CRD, were
also shown in bar charts. The Ca2+ transient and motion data were obtained independently. In all the bar charts, values are means ± SE and are expressed as percentage of control.
184 T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191occurred locally in the cell body. Therefore, it should not be surprising
that the average velocity of hiPS-CMs would not correlate well with
their cell area. It has been reported that hiPS-CMs cultured for
prolonged period, e.g., 90 days, exhibited rod-shaped morphology [66]
like adult CMs ﬁlled with an aligned sarcomere structure [67]. Those
morphologically matured hiPS-CMs, which were not tested in this
study, could represent area dependence of contractile speed.
The image-based edge-detection technique has been the method
of choice for measuring the shortening of the length of the whole cell
body or sarcomere of the rod-shaped adult CMs in order to estimatethe force development [34,41–43]. In contrast, TFM has been utilized
to assess the contractility of cultured CMs that exhibit an amorphous
shape [26,68,69]. With TFM, the traction force of the cells can be es-
timated based on the deformation of the substrate, which is detected
by the displacement of ﬂuorescent beads embedded in the substrate,
and on the elastic modulus of the substrate [70]. In our study, we ex-
amined the correlation between the force development and cellular
deformation (ADD) of the hiPS-CMs. As shown in Fig. 2B, ADD ap-
peared to be correlated with the force development on the sub-
strates (12 kPa and 50 kPa). Phase-contrast microscopy observes
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Fig. 4. (A) Phase-contrast image of the hiPS-CMmonolayer prepared on the MEA probe. (B) The enlarged velocity ﬁeld image for the yellow-square region is shown in (A), which shows
the motion vectors as ﬁne white lines. (C) Example proﬁle of simultaneously measured hiPS-CM motion and FP. The motion data were evaluated from the region in close vicinity to the
electrode (e.g., the yellow-square region in Fig. 4A) that was used for the FP data acquisition. (D) An enlarged single beat proﬁle. The horizontal dashed line represents the baseline of
the average velocity (0 μm/s). The vertical dot–dashed lines illustrate the durations of contraction and relaxation of the motion proﬁle. The vertical dashed line with the arrow shows
the peak position of positive deﬂection of the FP. (E)Magniﬁedﬁgure of the onset region of the FP and themotion shown in (D). Time zero corresponds to the onset of the positive FP spike.
185T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191overall deformation/displacement of hiPS-CMs during the contrac-
tion–relaxation process, including passively moving cellular bound-
aries and intracellular compartments or organelle. Our present
results suggested that the average cellular deformation, ADD, detect-
ed by phase-contrast microscopy and motion vector analysis repre-
sents the extent of the force development of the hiPS-CMs on the
substrates. As long as intra- and extra-cellular elastic properties
(e.g., adhesion between hiPS-CMs and substrate) of hiPS-CMs are
not altered during the measurement, ADD can be a surrogate marker
for the force development of hiPS-CMs.Isoproterenol and verapamil have been shown to alter the amplitude
of the ﬂuorescence peak of the Ca2+ transient in iPS-CMs [19]. In our
current study, we examined whether the Ca2+ transient of hiPS-CMs
was correlated with motion behavior in the presence of isoproterenol
and verapamil. Responses of the Ca2+ transient in hiPS-CMs observed
against isoproterenol included an increase in the amplitude, upstroke
and decay (Fig. 3A). Interestingly, themaximumdecay of the Ca2+ tran-
sient in the presence of isoproterenol showed a higher increased rate
(~160% increase from control) compared to that of maximum upstroke,
which is consistentwith greater increases inMRS than inMCS ofmotion
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186 T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191response. Verapamil decreased all of the parameters of the Ca2+ tran-
sient in hiPS-CMs (Fig. 3C, D). This is attributed to verapamil's blockage
of the L-type Ca2+ channel, which is supported by the FP data shown
in Fig. 7C. Thus, decreased contraction and relaxation speeds as well
as ADD of hiPS-CMs in the presence of verapamil (Fig. 7D and E) can
also be attributed to decreased cytoplasmic Ca2+ concentration associ-
ated with the Ca2+-induced Ca2+ release mechanism. Taken together,
these data suggest that the cellular deformation in the hiPS-CMmonolayer shows a correspondence to the cytoplasmic Ca2+ status,
observed with a common ﬂuorescence indicator.
4.2. Correlation between the FP and contractile motion of the hiPS-CMs
Our simultaneous measurements of motion and FP conﬁrmed the
following correlations under non-arrhythmic conditions: 1) CRD is
longer than the FPD; 2) the onset of contraction motion follows the
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187T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191occurrence of the Na+ current peak of FP; and 3) the position of the
negative broad deﬂection in FP occurs with the contraction.We also ob-
served relationships 1) and 2), but not 3), in neonatal rat CMs. It is note-
worthy that while we found the motion proﬁle of hiPS-CMs exhibited a
certain amount of displacement (velocity) at the minimum point be-
tween contraction and relaxation peak (Figs. 1 and 4), neonatal ratCMs showed almost no displacement (velocity) at the same position
(Supplementary Fig. 2). While this observation for the hiPS-CMs ap-
peared to be derived from the lack of any synchronized motion at the
end of the contraction, the precise mechanism for this phenomenon re-
mains unclear. Differences in the contractionmotion between hiPS-CMs
and rat CMs may reﬂect the presence and absence of the plateau phase
0.215
(A)
control
e
ra
ge
 sp
ee
d 
[µm
/s
]
Field potential [ m0.05
0.1
0.15
0
5
10
30 nM
90 nM
Motion
Av
e
m
V]
0
-0.05
-0.1
0 400 800
FP
Time [ms]
400
500
(B)
FP
D
 [m
s]
200
R = 0.970100
300
CRD [ms]
300
0
120 MCS
MRS
(C)
140
500 700
(D) (E)
120 #
#
200 400 600
%
co
nt
ro
l
40
60
80
100
tin
g 
ra
te
 (%
co
ntr
ol)
40
60
80
100
120
40
60
80
100
**
**
#
#
*
#
#
#
**
#
#
AD
D
 (%
co
ntr
ol)
FPslow
0
20
Cont. 30 90 150
Verapamil [nM]
Cont. 30 90 150
Verapamil 
[nM]
Cont. 30 90 150
Verapamil 
[nM]
Be
at
0
20
0
20
A
Fig. 7. Contractile and FP responses of the hiPS-CM to verapamil. (A) Example of themotion and FP proﬁles of the hiPS-CMs simultaneouslymeasured in the presence of 0, 90, and 150 nM
of verapamil. (B) Correlation of the CRD and FPD obtainedwith varied concentrations of verapamil (0–270 nM). Dotted line is a linear regression ﬁtted to the data with R= 0.970 and the
slope = 0.633 (FPD/CRD). (C) Change of the rate of the MCS, MRS and the amplitude of FPslow. The amplitude of FPslow was evaluated by averaging the FP value for 6 ms (between 3 ms
before and 3 ms after the point of the peak of the contraction motion). (E) and (F) show the normalized change of ADD and beating rate, respectively. Data were obtained from 5 to 8
independent preparations of the hiPS-CMmonolayer. In (C)–(E), values are expressed as means ± SE. *p b 0.05; **p b 0.01 and #p b 0.10 compared with the control.
188 T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191of their action potential [71–73]. Alternatively, it may be relevant to the
immaturity of hiPS-CM sarcoplasmic reticulum, as suggested for hES-
CMs [28,29].
We performed a simultaneous measurement of motion and FP from
the hiPS-CM monolayer in the presence of TTX, E-4031, verapamil and
isoproterenol. The experiments revealed a linear relationship between
the CRD and FPD in the presence of E-4031 (10–50 nM), verapamil
(30–150 nM) and isoproterenol (0.1–10 μM). Although the slope of
the CRD–FPD relationship was suggested to be different in each drug,
the present results suggested that the CRD can be a surrogate of
the FPD in non-arrhythmic conditions. However, it should be notedthat the lower time resolution of motion vector (~6 ms data interval)
compared to that of FP (0.05 ms data interval) could be of concern.
Due to the blockage of IKr with E-4031, it is reasonable to assume
that the relaxation speed was decreased at the point where the K+
current occurred. With regard to the duration, even in the presence of
10–50 nM E-4031, the proﬁle of CRD–FPD correlation appeared to be
well correlated with the correlation coefﬁcient of R = 0.915, and the
slope of the linear regression was 1.362 (FPD/CRD) (Fig. 6B). This
slope value appeared to be signiﬁcantly larger than the case of verapa-
mil (0.633 (FPD/CRD)) shown in Fig. 7B. This may be relevant to the ab-
normalities in electro-mechanical relationship reported for the Torsade
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189T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191de Pointes-genic drugs [74–76]. However, to determine the precise rela-
tion between FPD and CRD, it is necessary to determine FPD accurately
even when the extensive broadening occurred and to consider the
beating rate, which is beyond the scope of the present paper and
is needed to be examined in a further study. In the presence of
50–100 nM E-4031, the EAD-like negative deﬂection in the FP wave-
form was observed. EADs are caused by the re-activation of the
inactivated L-type Ca2+ current or the inactivated voltage-dependent
Na+ current, with the latter associated with the activation of the for-
ward cycle of the Na+/Ca2+ exchanger and the resultant Ca2+ inﬂux.Thus, it is conceivable that the EAD is associated with the transient
increase in the intracellular Ca2+ concentration, which leads to a reduc-
tion of the relaxation motion speed before completion of the relaxation
process, thereby resulting in the appearance of another motion peak at
the end of relaxation (Fig. 6C). As recognized in the video images of
hiPS-CMs in the presence of 100 nM E-4031 (Supplementary video 2),
however, such additional single peaks were a part of relaxation motion,
not of an independent contraction–relaxation motion. After the occur-
rence of this type of two-step relaxation motion, triggered activity
followed by arrhythmic beating were often observed (data not
190 T. Hayakawa et al. / Journal of Molecular and Cellular Cardiology 77 (2014) 178–191shown). EAD-induced contraction, or triggered activity, was also report-
ed using a video edge-detection system for hiPS-CMs in the presence
of E-4031 [77]. The occurrence of another motion peak at the end of
relaxation could be a potential marker for the early detection of EAD.
Verapamil increased the beating rate of hiPS-CM (Fig. 7E). Although
this effect would not be expected to occur based on verapamil's mecha-
nism of action and previous clinical ﬁndings [78–80], verapamil has
been reported to have a positive chronotropic effect on hES-CMs [54].
In accordance with the concentration of verapamil used in the current
study, decreases were observed in MCS and in the amplitude of FPslow.
FPslow was also decreased under Ca2+-free condition in embryonic
mouse CMs and was suggested to reﬂect the current of L-type Ca2+
channel [55]. Although FPslow does not solely represent the extent of
the Ca2+ current, their relative values (% of control)were in good agree-
ment with those of the MCS.
Isoproterenol was also observed to increase beating rate, MCS, MRS
and ADD. The increasing rate of maximum velocity was greater during
relaxation (176% at 10 μM, n = 7) versus that during contraction
(126% at 10 μM, n = 7) (Fig. 8C). Although the precise reason for
these ﬁndings is currently unknown, Turnbull et al. described the negli-
gible inotropic response of hES-CMs against isoproterenol and pointed
out the immaturity of the sarcoplasmic reticulum of the hES-CMs [29].
Pillekampt et al. also reported that isoproterenol signiﬁcantly induced
positive chronotropy and lusitropy but not inotropy in early hES-CMs
[28]. The mechanism underlying the hES-CMs ﬁndings in their study
could be relevant to our current hiPS-CM observations. On the other
hand, the FP proﬁle showed no major alterations by the addition of
isoproterenol with the exception of the shortening in FPD. Although
the L-type Ca2+ channel is one of the targets of the isoproterenol action,
alterations in FPslow were not clearly detected with isoproterenol. This
could be partly due to that negative deﬂection in FP does not solely re-
ﬂect the L-type Ca2+ current, since the FP is an extracellular potential
and not a cell membrane potential.
4.3. Variability in the contractile data
To someextent, the absolute values ofMCS andMRS of hiPS-CMs de-
pend on themonolayer region (Supplementary Fig. 3A). The reasons for
this regional heterogeneity can be considered to be as follows: 1) the
cell density may not be thoroughly homogeneous in the well, 2) the
cell size and contractile characteristics have some variability, 3) the
hiPS-CM monolayer contains a certain amount of non-cardiac (non-
contracting) cells (~2%), and 4) the monolayer preparations contain a
variety of shapes and types (atrial-, ventricular- and nodal-type) of
hiPS-CMs. However, as long as we evaluate the contractile parameters
from the same ﬁeld of view in the monolayer and express the parame-
ters using a relative value (i.e., % of the control), the inter-region
variability of the contractile parameters should be fairly small
(Supplementary Fig. 3B). It is possible that non-cardiac cells may have
affected the contractile properties of our cultures because those cells
move passively with lower motion speed than that of contracting
hiPS-CMs. However, we assumed that theywere present to a similar ex-
tent in all regions in the monolayer and hence should not have affected
the validity of our results.
In conclusion, this study demonstrated that the contractilemotion of
2D cultured hiPS-CMs, detected by a high-speed camera and motion
vector analysis, quantitatively corresponded to their electrophysiologi-
cal and functional behaviors under non-arrhythmic condition. Although
the relationship between hiPS-CM motion and FP during excitation–
contraction decoupling or proarrhythmic conditions is of great interest,
it is not within the scope of this current paper andwill need to be exam-
ined in a further study. The results of the present study will open up the
possibilities of detecting cellular-level information on the electric and
mechanical relationship of cultured CMs and will contribute to expand
the applicability of hiPS-CMs in the ﬁeld of cellular cardiology, drug
screening and cardiac therapeutics.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.yjmcc.2014.09.010.Disclosure Statement
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